Patent details
LUC50035
Product Name:
Élinzanétant
Basic Information
- Publication number:
- LUC50035
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP167231075
- Legal Status:
- Pending & Published
- Application number:
- LUC50035
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/25/1991
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 18/11/2025
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 20/01/2026
- First Marketing Authorization date:
- 18/11/2025
- Grant date:
- Activation date:
- Publication date:
- 21/01/2026
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 18/11/2040
- SPC Extension Expiration:
- 18/11/2040
- Rejection date:
- Withdrawal date:
Owner
- From:
- 20/01/2026
-
-
- Name:
- KANDY THERAPEUTICS LIMITED
- Address:
- 400 South Oak Way,
Reading, RG2 6AD, Berkshire, United Kingdom (GB)
Agent
- Name:
- ARONOVA S.A.
- From:
- 20/01/2026
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Publication
Bulletin
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2026/03
- Publication date:
- 05/02/2026
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
Annual Fees
- Annual Fee Due Date:
- 02/06/2036
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-